Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo in 1993 as a first generation internet teaching tool consolidating human embryology teaching for first year medical students.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human.

The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

December 6, 2012--------News Archive Return to: News Alerts

Photo: ALAMY

Researchers calculate that men, average age of 35, have semen concentrations which
have declined from an average of 73.6 million/ml in 1989 to 49.9 million/ml in 2005.

WHO Child Growth Charts


Semen Quality Fell in French Men Between 1989 and 2005

New research shows that the concentration of sperm in men's semen has been in steady decline between 1989 and 2005 in France. In addition, there has been a decrease in the number of normally formed sperm

The study is published online in Europe's leading reproductive medicine journal Human Reproduction.

The study is important because, with over 26,600 men involved, it is probably the largest studied sample in the world and although the results cannot be extrapolated to other countries, it does support other studies from elsewhere that show similar drops in semen concentration and quality in recent years.

The researchers used the French assisted reproduction
technology (ART) database Fivnat, which collected
data from 126 main ART centres in France.

They examined semen samples provided by men
who were the partners of women undergoing fertility
treatment because their Fallopian tubes were blocked
or missing – in other words, the couples' infertility
was due to these problems rather than to
any problems with the men's sperm.

They found that over the 17-year period there was a significant and continuous 32.2% decrease in semen concentration (millions of spermatozoa per millilitre of semen), at a rate of about 1.9% per year. The researchers calculated that in men of the average age of 35, semen concentrations declined from an average of 73.6 million/ml in 1989 to 49.9 million/ml in 2005.

In addition, there was a significant 33.4% decrease in the percentage of normally formed sperm over the same period. Changes in the way sperm shape (morphology) was measured during this time may partly explain this decrease and make it difficult to give an estimate for the general population. However, the researchers say that these changes do not account for the total decrease in the quality of sperm morphology observed over the study period.

In their paper, the researchers write:

"To our knowledge, it is the first study concluding
a severe and general decrease in sperm concentration
and morphology at the scale of a whole country over
a substantial period. This constitutes a serious public
health warning. The link with the environment
particularly needs to be determined."

One of the authors, Dr Joëlle Le Moal, an
environmental health epidemiologist at the Institut de
Veille Sanitaire, Saint Maurice, France, said:

"The decline in semen concentration shown in our
study means the average values we have for 2005
fall within the 'fertile' range for men according to
the definition of the World Health Organisation.

However, this is just an average, and there were
men in the study who fell beneath the WHO values.
The 2005 values are lower than the 55 million/ml
threshold, below which sperm concentration is
expected to influence the time it takes to conceive."

The researchers also looked at how well the sperm moved (motility) and found that the proportion of motile sperm increased slightly from 49.5% to 53.6% between 1989 and 2005.

Although they made adjustments for variables that could affect the results, such as the men's ages, the season, the centre where they gave their sperm samples, and the technique (standard in vitro fertilisation or intra-cytoplasmic sperm injection), they were unable to control for socioeconomic factors, including smoking and weight, which can affect semen quality and concentration.

However, the authors say that, even though ART is equally accessible to the whole population, it tends to be the better educated who undergo it in France and they are less likely to smoke and to be overweight. "Therefore, the real values for sperm parameters in the general population could be slightly lower than those that we present and the decreases could possibly be stronger," they write.

The authors say that there needs to be more
research into the possible causes for the decline
in semen concentration and percentages of
normally formed sperm. But, other studies point to
the role played by environmental factors such as
endocrine disruptors (chemicals that disturb
the body's normal hormonal balance).

Furthermore, such factors could induce epigenetic
changes (changes in the way genes and cells behave)
that might be passed down the generations, and
which could contribute to a longer process of
decline in men's fertility.

Dr Le Moal said: "Impairments in the quality of human gametes (male sperm and female eggs) can be considered as critical biomarkers of effects for environmental stresses, including endocrine disrupters. Firstly, this is because gametes are the very first cells from which human beings are built up during their lifetimes. According to the theories about the developmental origins of health and diseases, early (foetal, postnatal, but possibly also preconceptional) exposures may have an impact on adult health; the testicular dysgenesis syndrome hypothesis could be regarded as an example.

"Secondly, it has been shown in humans and animals that intergenerational effects may occur after foetal exposures, particularly via epigenetic changes. If such exposures and effects occur in successive generations, accumulated outcomes are plausible. So the observed trends could be the result of several generations' changes."

For this reason, the authors say they are concerned that there could be effects on the next generation's health.

Dr Le Moal "Our public health warning may help health authorities to reinforce their actions on endocrine disruptors, hopefully at the European level, and to sustain research as well as monitoring systems. We plan to implement a national monitoring system with the French competent authority (the Biomedicine Agency), which now runs the national registry of ART. Our example could help other countries to implement their own systems. International monitoring systems could be a good idea to understand what is happening on human reproductive outcomes around the world, and evaluate public health actions in future."

Original article: http://www.eshre.eu/page.aspx/1780